The findings of an initial virtual survey that was presented at the 2021 Genitourinary Cancers Symposium demonstrate that the coronavirus pandemic had a negative influence on patients who suffer from genitourinary malignancies. Genitourinary cancers are mainly found in the male reproductive system and the urinary system. These cancers include adrenal cancer, testicular cancer, urethral cancer, bladder cancer, kidney cancer, prostate cancer and cancers of the penis.
The preliminary survey highlights that as a result of the pandemic, almost 12% of study participants missed at least one dose of a prescribed medication, 12% avoided making the trip to a pharmacy to receive required medication, and roughly 17% reported that they avoided or delayed seeking medical care. Another 26% reported…
NOTE TO INVESTORS: The latest news and updates relating to Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) are available in the company’s newsroom at https://ibn.fm/IMEXF
About BioMedWire
BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.
To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)
For more information, please visit https://www.BioMedWire.com
Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer
BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
Editor@BioMedWire.com
BioMedWire is part of the InvestorBrandNetwork.
